DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
  • Stocks
  • /
  • Materials
Updated 1d ago
BIOXD logo

Bioceres Crop Solutions Corp.BASE:BIOXD Stock Report

Market Cap US$23.4m
Updated 1d ago
Share Price
n/a
1Y-78.0%
7D-11.7%
1D-3.6%
Portfolio Value
​
View

Bioceres Crop Solutions Corp.

BASE:BIOXD Stock Report

Market Cap: US$23.4m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Bioceres Crop Solutions (BIOXD) Stock Overview

Develops and commercializes crop productivity solutions. More details

BIOXD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the AR market

Earnings have declined by 51.6% per year over past 5 years

Does not have a meaningful market cap ($23M)


BIOXD Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW427,144 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
427,144 investors already sharing narratives
US$
Current Price
US$0.3892.8% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-55m465m2016201920222025202620282031Revenue US$297.2mEarnings US$27.9m
Advanced
View all narratives

Bioceres Crop Solutions Corp. Competitors

Rigolleau

Symbol: BASE:RIGO
Market cap: AR$56.7b

Celulosa Argentina

Symbol: BASE:CELU
Market cap: AR$19.8b

Fiplasto

Symbol: BASE:FIPL
Market cap: AR$23.5b

Pato Chemical Industry

Symbol: SET:PATO
Market cap: ฿889.8m

Price History & Performance

Summary of share price highs, lows and changes for Bioceres Crop Solutions
Historical stock prices
Current Share PriceUS$0.38
52 Week HighUS$2.40
52 Week LowUS$0.32
Beta0.43
1 Month Change-10.24%
3 Month Change-7.60%
1 Year Change-77.95%
3 Year Change-96.78%
5 Year Change-97.39%
Change since IPO-97.48%

Recent News & Updates

Recent updates

Shareholder Returns

BIOXDAR ChemicalsAR Market
7D-11.7%-0.5%-2.1%
1Y-78.0%17.1%79.1%

Return vs Industry: BIOXD underperformed the AR Chemicals industry which returned 17.1% over the past year.

Return vs Market: BIOXD underperformed the AR Market which returned 79.1% over the past year.

Price Volatility

Is BIOXD's price volatile compared to industry and market?
BIOXD volatility
BIOXD Average Weekly Movement9.1%
Chemicals Industry Average Movement3.5%
Market Average Movement4.4%
10% most volatile stocks in AR Market6.3%
10% least volatile stocks in AR Market3.1%

Stable Share Price: BIOXD's share price has been volatile over the past 3 months compared to the AR market.

Volatility Over Time: BIOXD's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of AR stocks.

About the Company

FoundedEmployeesCEOWebsite
2001751Federico Truccoinvestors.biocerescrops.com/home/default.aspx

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops.

Bioceres Crop Solutions Corp. Fundamentals Summary

How do Bioceres Crop Solutions's earnings and revenue compare to its market cap?
BIOXD fundamental statistics
Market capUS$23.36m
Earnings (TTM)-US$46.90m
Revenue (TTM)US$237.80m
0.1x
P/S Ratio
-0.5x
P/E Ratio

Is BIOXD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOXD income statement (TTM)
RevenueUS$237.80m
Cost of RevenueUS$155.30m
Gross ProfitUS$82.50m
Other ExpensesUS$129.40m
Earnings-US$46.90m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.74
Gross Margin34.69%
Net Profit Margin-19.72%
Debt/Equity Ratio352.4%

How did BIOXD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/18 02:26
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2026/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bioceres Crop Solutions Corp. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian Kemp DolliverBrookline Capital Markets
Austin MoellerCanaccord Genuity

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide